President and CEO, Mount Sinai Health System (Festival Underwriter); Trustee, The Aspen Institute
Kenneth L. Davis is CEO and president of Mount Sinai Health System. He is a leader in the move away from fee-for-service medicine to population health, aiming to keep more patients healthy and out of the hospital. As a neurobiologist, his research led the FDA to approve four of the first five drugs to treat Alzheimer’s disease. An elected member of the Institute of Medicine and author of more than 575 scientific articles, Davis is a highly cited researcher in the field of brain diseases. His numerous honors include the George H. W. Bush Lifetime of Leadership Award from Yale University. He is a trustee of the Aspen Institute.